Nomura

Nomura has cut at least 20 people from its credit trading business, according to two sources outside the bank, with the high yield business hit particularly hard.

Citigroup has hired Stephen Roti to head its global corporate equity derivatives team.

Alkem Laboratories, a drug manufacturer, has lodged its preliminary prospectus with India’s regulator for a listing that could raise some $200m. The trade will be led by two local and two international banks.

Belgian and German medical diagnostics provider Amedes brought some investors who had initially declined the €525m loan back into the fold this week as deal supply fell.

A pair of rare SSA names kept Kangaroo supply ticking over this week with taps of longer-dated deals.

Swedish Export Credit Corporation made a rare appearance at the long end of the Australia’s Kangaroo market on Wednesday.

Belgian and German medical diagnostics provider Amedes bought some investors who had initially declined the €525m loan back into the fold this week as deal supply fell.

Nomura has hired Shantanu Sahai from Barclays as its executive director in debt capital markets Asia ex-Japan to drive its Indian bond business, according to an internal memo seen by GlobalCapital Asia.

The primary market for peripheral European covered bonds leapt back to life this week after a 12 week hiatus, with investors queuing up to buy a series of deals that emerged in quick succession.

In what was hailed as a momentous, perhaps record breaking, week in high yield finance, Japanese telecoms operator SoftBank took the crown by raising the year’s biggest Asian offshore high yield deal, writes Victor Jimenez.

Armed with a strengthened credit rating, Nomura is upgrading in Europe and plans a US expansion, targeting $1bn of international corporate finance revenues by 2018, writes David Rothnie.

The European Stability Mechanism comfortably raised the €2bn it needed from a tap issue on Tuesday — but there were doubts as to whether it has reopened the euro market for SSAs.